胰腺癌靶向

Pancreatic cancer targeting

以上为机器翻译结果，快速获取精准的人工翻译结果，建议选择有道人工翻译

1
我们研究关于间皮素作为胰腺疾病及胰腺癌靶向治疗的潜在临床应用。
We conducted a study on the potential clinical utility of mesothelin as a biomarker for pancreatic disease and therapeutic target pancreatic cancer.
2
研究显示间皮素可作为胰腺癌患者以免疫治疗为基础的潜在的靶向治疗策略。
This suggests that mesothelin is a potential target for immune-based intervention strategies in pancreatic cancer.
3
本文主要叙述已开展临床试验的治疗胰腺癌的靶向药物进展。
This review describes some of the important developments and targeted agents for pancreatic cancer that have been tested in clinical trials.

点击反馈